The Pharmacy Times® Cardiovascular Health Resource Center is a comprehensive resource for clinical news and expert insights on the health of the heart and blood vessels, including coronary heart disease, stroke, heart failure, heart arrhythmias, and heart valve issues.
April 30th 2024
At Asembia's AXS24 Summit, a clinician discusses the pathophysiology and classification of pulmonary arterial hypertension.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels
0.75 Credit / Cardiology
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Introduction to Anticoagulation and the Appropriate Patient
1.0 Credit / Cardiology
View More
The Treatment Landscape and a Review of Approved DOAC Agents
1.0 Credit / Cardiology
View More
Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management
1.0 Credit / Cardiology
View More
Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction
1.0 Credit / Cardiology
View More
Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia
1.0 Credit / Cardiology
View More
Understanding the Challenges of Homozygous Familial Hypercholesterolemia
1.0 Credit / Cardiology
View More
The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings
1.0 Credit / Cardiology
View More
Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fraction
1.0 Credit / Cardiology
View More
Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and Improving Adherence
1.0 Credit / Cardiology
View More
Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration
1.0 Credit / Cardiology
View More
Iron Deficiency and Anemia in Heart Failure: Clinical Applications for the Use of Intravenous Iron
1.5 Credits / Cardiology
View More
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
1.0 Credits / Cardiology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Lipoprotein(a) and Beyond: Emerging Paradigms in Atherosclerotic Cardiovascular Disease Prevention
1.5 Credits / Cardiology
View More
Optimizing Care for Chronic Worsening Heart Failure: The Key Role of Pharmacists in Integrating Therapies
1.5 Credits / Cardiology
View More
The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney Disease
1.5 Credits / Cardiology; Endocrinology, Diabetes & Metabolism; Nephrology
View More
Statins May Reduce Mortality Risk in Prostate Cancer Patients
November 12th 2013Risk of death from prostate cancer was reduced for patients who started taking statins after being diagnosed with the disease and was reduced even more for those who started taking statins before being diagnosed.
Read More
Multidisciplinary Teams Including Pharmacists Improve Heart Failure Outcomes
October 4th 2013Pharmacists working along with other health care providers can help improve outcomes for heart failure patients, according to the results of a pair of studies presented at the Heart Failure Society of America meeting.
Read More
Combination Pill Improves Adherence in Cardiovascular Disease Patients
September 5th 2013Patients with or at high risk for cardiovascular disease who took a pill that combined aspirin, a statin, and 2 antihypertensives had significantly higher adherence levels than those who received usual care.
Read More
Health Care Costs May Limit Treatment for Hypertensive Patients
August 23rd 2013A review of 53 studies finds that hypertension patients with health insurance were more likely to be adherent to antihypertensive medication and to have their hypertension under control than were those without insurance.
Read More
Triple Therapy With New Anticoagulants Suitable for Highest-Risk Patients
June 3rd 2013A literature review finds that triple therapy including newer anticoagulants, aspirin, and clopidogrel may increase the risk of bleeding and should be limited to patients at highest risk for thromboembolic events.
Read More